• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

VOLITIONRX LIMITED

Notes

No. Proposition For Against Abstain
1

DIRECTOR Dr. Phillip Barnes

2

DIRECTOR Dr. Alan Colman

3

DIRECTOR Mickie Henshall

4

DIRECTOR Guy Innes

5

DIRECTOR Kim Nguyen

6

DIRECTOR Cameron Reynolds

7

DIRECTOR Dr. Ethel Rubin

8

DIRECTOR Timothy Still

9

To ratify the selection of Sadler, Gibb & Associates, LLC as the Companys independent registered public accounting firm for the year ending December 31, 2025.

10

To approve, by a non-binding advisory vote, the compensation of the Companys named executive officers.

11

To approve a second amendment to the Companys Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Companys common stock, $0.001 par value per share, from 175,000,000 to 325,000,000.